Peterson, J F, J R Field, Y Shi, J S Schildcrout, J C Denny, T L McGregor, S L Van Driest, et al. 2016. “Attitudes of Clinicians Following Large-Scale Pharmacogenomics Implementation.” The Pharmacogenomics Journal 16 (4): 393–98. doi:10.1038/tpj.2015.57.

Peterson, Jf, Jr Field, Km Unertl, Js Schildcrout, Dc Johnson, Y Shi, I Danciu, et al. 2016. “Physician Response to Implementation of Genotype-Tailored Antiplatelet Therapy.” Clinical Pharmacology & Therapeutics 100 (1): 67–74. doi:10.1002/cpt.331.

Schildcrout, Jonathan S., Joshua C. Denny, and Dan M. Roden. 2017. “On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance Database.” Drug Safety 40 (1): 1–2. doi:10.1007/s40264-016-0476-z.

Schildcrout, Jonathan S., Yaping Shi, Ioana Danciu, Erica Bowton, Julie R. Field, Jill M. Pulley, Melissa A. Basford, et al. 2016. “A Prognostic Model Based on Readily Available Clinical Data Enriched a Pre-Emptive Pharmacogenetic Testing Program.” Journal of Clinical Epidemiology 72 (April): 107–15. doi:10.1016/j.jclinepi.2015.08.028.

Unertl, Kim M, Julie R Field, Lisa Price, and Josh F Peterson. 2015. “Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.” Personalized Medicine 12 (4): 339–47. doi:10.2217/pme.15.10.

Wiley, Laura K., Jacob P. Vanhouten, David C. Samuels, Melinda C. Aldrich, Dan M. Roden, Josh F. Peterson, and Joshua C. Denny. 2016. “STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.” Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 22: 545–56.

Batsis, John A., Sarah N. Pletcher, and James E. Stahl. 2017. “Telemedicine and Primary Care Obesity Management in Rural Areas – Innovative Approach for Older Adults?” BMC Geriatrics 17 (1). doi:10.1186/s12877-016-0396-x.